Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C

Gene Therapy

Volumn 4, Issue 10, 1997, Pages 1077-1084

  Zeng, L ^a   Quilliet, X ^a   Chevallier Lagente, O ^a   Eveno, E ^a   Sarasin, A ^a   Mezzina, M ^a  

^a UPR 42 CNRS   (France)

Author keywords

DNA repair genes; Retroviral vectors; Skin cancer therapy; Xeroderma pigmentosum

Indexed keywords

COMPLEMENTARY DNA; DNA; RNA;

ARTICLE; CASE REPORT; CELL IMMORTALIZATION; CONTROLLED STUDY; DNA REPAIR; EXPRESSION VECTOR; FIBROBLAST; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC COMPLEMENTATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; RETROVIRUS; RNA SYNTHESIS; TRANSGENE; UNSCHEDULED DNA SYNTHESIS; VIRUS RECOMBINANT; XERODERMA PIGMENTOSUM;

UNIDENTIFIED RETROVIRUS;

EID: 0030782132     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300495     Document Type: Article

References (51)

1. Cleaver JE. Defective repair replication of DNA in xeroderma pigmentosum. Nature 1968; 218: 652-656.
2. Kraemer KJ, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous ocular and neurological abnormalities in 830 published cases. Arch Dermatol 1987; 123: 241-250.
3. Robbins JH. Defective DNA repair causes skin cancer and neurodegeneration. JAMA 1988; 260: 384-388.
4. Sarasin A. The paradox of DNA repair deficient diseases. Cancer J 1991; 4: 233-237.
5. Robbins JH et al. Xeroderma pigmentosum. An inherited disease with sun sensitivity, multiple cutaneous neoplasms and abnormal DNA repair. Ann Intern Med 1974; 80: 221-248.
6. Takebe H et al. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan. Cancer Res 1977; 367: 490-495.
7. Cleaver JE, Kraemer KH. Xeroderma pigmentosum. In: Scriver CR, Beaudet al, Sly WS, Valle D (eds). The Metabolic Basis of inherited Diseases, vol. 2. McGraw Hill: New York, 1989, pp 2949-2971.
8. Cleaver JE. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc Natl Acad Sci USA 1969; 63: 428-435.
9. Setlow RB, Regan JD, German J, Carrier WL. Evidence that xeroderma pigmentosum cells do not perform the first step in the repair of ultraviolet damage to their DNA. Proc Natl Acad Sci USA 1969; 64: 1035-1041.
10. Lehmann AR et al. Xeroderma pigmentosum cells with normal levels of excision repair have a defect in DNA synthesis after UV irradiation. Proc Natl Acad Sci USA 1975; 72: 219-223.
11. Busch D et al. Summary of complementation groups of UV-sensitive CHO cell mutants isolated by large-scale screening. Mutagenesis 1989; 4: 349-354.
12. Riboni R et al. Identification of the eleventh complementation group of UV-sensitive excision repair-defective rodent mutants. Cancer Res 1992; 52: 6690-6691.
13. Weeda G et al. A presumed DNA helicase encoded by ERCC-3 is involved in the human repair disorders xeroderma pigmentosum and Cockayne's syndrome. Cell 1990; 62: 777-791.
14. Flejter WL et al. Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: involvement of the human ERCC2 DNA repair gene. Proc Natl Acad Sci USA 1992; 89: 261-265.
15. Sijbers AM et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell 1996; 86: 811-822.
16. O'Donovan A, Wood RD Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5. Nature 1993; 363: 185-188.
17. Troelstra C et al. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 1992; 71: 939-953.
18. Aboussekhra A et al. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell 1995; 80: 859-868.
19. Weeda G, Hoejimakers JHJ. Genetic analysis of nucleotide excision repair in mammalian cells. Semin Cancer Biol 1993; 4: 105-107.
20. Schaeffer L et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 1993; 260: 58-63.
21. Drapkin R et al. Dual role of TFIIH in DNA excision repair and in transcription by RNA polymerase II. Nature 1994; 368: 769-772.
22. van Vuuren A et al. Correction of xeroderma pigmentosum repair defect by basal transcription factor BTF2 (TFIIH). EMBO J 1994; 13: 1645-1653.
23. Davis BE et al. Sunlight avoidance and cancer prevention in xeroderma pigmentosum. Arch Dermatol 1994; 130: 806-808.
24. Atabay K et al. Facial resurfacing in xeroderma pigmentosum with monoblock full-thickness skin graft. Plast Reconstr Surg 1991; 87: 1121-1125.
25. Mezzina M et al. Correction by the ERCC2 gene of UV sensitivity and repair deficiency phenotype in a subset of trichothiodystrophy cells. Carcinogenesis 1994; 15: 1493-1498.
26. Gözükara EM et al. The human DNA repair gene, ERCC2 (XPD), corrects ultraviolet hypersensitivity and ultraviolet hypermutability of a shuttle vector replicated in xeroderma pigmentosum group D cells. Cancer Res 1994; 54: 3837-3844.
27. Clinical Protocols. Cancer Gene Therapy 1994; 1: 73-78.
28. Carreau M et al. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients. Human Gene Ther 1995; 6: 1307-1315.
29. Quilliet X et al. Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene. Mutation Res 1996; 364: 161-169.
30. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988; 85: 6460-6464.
31. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
32. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7: 980-989.
33. Mayne LV, Lehmann AR. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res 1982; 42: 1473-1478.
34. Venema J et al. The genetic defect in Cockayne's syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci USA 1990; 87: 4707-4711.
35. Vermeulen W et al. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet 1994; 54: 191-200.
36. Cleaver J, Kraemer KH. Xeroderma pigmentosum and Cockayne syndrome. In: Scriver CR, Beaudet al, Sly WS, Valle D (eds). The Metabolic and Molecular Basis of Inherited Disease, 7th edn. McGraw Hill: New York, 1995, pp 4393-4419.
37. Robins P et al. Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA. EMBO J 1991; 10: 3913-3921.
38. Asahina H et al. The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DMA damage. Mutat Res 1994; 315: 229-237.
39. Kuraoka I et al. Identification of a damaged-DNA binding domain of the XPA protein. Mutat Res 1996; 362: 87-95.
40. Satokata I et al. Three nonsense mutations responsible for group A xeroderma pigmentosum. Mutat Res 1992; 273: 193-202.
41. McDowell ML, Nguyen T, Cleaver JE. A single-site mutation in the XPAC gene alters photoproduct. Mutagenesis 1993; 8: 155-161.
42. Jones CJ, Cleaver JE, Wood RD. Repair of damaged DNA by extracts from a xeroderma pigmentosum complementation group A revertant and expression of a protein absent in its parental cell line. Nucleic Acids Res 1992; 20: 991-995.
43. Roy R et al. The DNA-dependent ATPase activity associated with the class II basic transcription factor BTF2/TFIIH. J Biol Chem 1994; 269: 9826-9831.
44. Weeda G et al. A mutation in the XPB/ERCC3 DNA repair transcription gene, associated with trichothiodystrophy. Am J Hum Genet 1997; 60: 320-329.
45. Masutani C et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J 1994; 13: 1831-1843.
46. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA repair deficient xeroderma pigmentosum patients Proc Natl Acad Sci USA 1993; 90: 10529-10533.
47. Li L, Bales ES, Peterson CA, Legerski RJ. Characterization of molecular defects in xeroderma pigmentosum group C. Nat Genet 1993; 5: 413-417.
48. Satokata I, Tanaka K, Yuba S, Okada Y. Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group A xeroderma pigmentosum. Mutat Res 1992; 273: 203-212.
49. Tanaka K et al. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and a zinc-finger domain. Nature 1990; 348: 73-76.
50. Weeda G et al. Molecular cloning and biological characterization of the human excision repair gene ERCC3. Mol Cell Biol 1990, 10: 2570-2581.
51. Sarasin A et al. Prenatal diagnosis in a subset of trichothiodystrophy patients defective in DNA repair. Br J Dermatol 1992; 127: 485-491.